AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States

AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousan…


– 출처 : https://www.newswire.co.kr/newsRead.php?no=1000655&sourceType=rss

함께 보면 좋은 콘텐츠